• Flanders Investment & Trade
  • Team Vesalius

Business leader Onno van de Stolpe began his career as business development manager at MOGEN in Leiden. 

Onno Van De Stolpe


Generaal De Wittelaan L11 A3
2800 Mechelen

He went on to work for the Netherlands Foreign Investment Agency in California (US), recruiting biotech and medical device companies to relocate to the Netherlands.

Van de Stolpe is now CEO of biotech pioneer Galapagos NV (Mechelen), a drug discovery and development company, which he founded in a joint venture with pharmaceutical company Tibotec, now part of Johnson & Johnson.

Team Vesalius visionairies

Flanders’ life sciences industry: the perfect combo of biotech, medtech, pharma and healthcare

Defining Flanders’ life sciences industry as diverse is an understatement. From young start-ups to established local firms and multinationals: the entire value chain – from research and discovery to development and commercialization – is represented in Belgium’s northern region. Thanks to fertile cross-pollination between biotech, medtech, pharmaceuticals and healthcare, Flanders offers a unique life sciences ecosystem that is underpinned by a robust financing landscape and a supportive government. Will your company claim its place in this dynamic hub?